Rhenman & Partners Asset Management AB grew its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 13.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 62,000 shares of the company’s stock after acquiring an additional 7,434 shares during the period. Rhenman […]